Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Nocloprost

😃Good
Catalog No. T33710Cas No. 79360-43-3
Alias ZK94726, ZK84726, ZK 94726, ZK 84726, SH475, SH 475

Nocloprost (SH 475) is a prostaglandin E2 (PGE2) analog, an EP1 and EP3 receptor agonist with local gastric protection and ulcer healing activity, reducing aspirin-induced gastrointestinal lesions, and inducing platelet activation, useful for studying cardiovascular diseases.

Nocloprost

Nocloprost

😃Good
Catalog No. T33710Alias ZK94726, ZK84726, ZK 94726, ZK 84726, SH475, SH 475Cas No. 79360-43-3
Nocloprost (SH 475) is a prostaglandin E2 (PGE2) analog, an EP1 and EP3 receptor agonist with local gastric protection and ulcer healing activity, reducing aspirin-induced gastrointestinal lesions, and inducing platelet activation, useful for studying cardiovascular diseases.
Pack SizePriceAvailabilityQuantity
100 μg$15335 days
500 μg$41535 days
1 mg$59035 days
Bulk & Custom
Add to Cart
Questions
View More
Select Batch
Concentration:1.0 mg/mL
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Nocloprost (SH 475) is a prostaglandin E2 (PGE2) analog, an EP1 and EP3 receptor agonist with local gastric protection and ulcer healing activity, reducing aspirin-induced gastrointestinal lesions, and inducing platelet activation, useful for studying cardiovascular diseases.
In vitro
In platelet-rich citrate plasma, Nocloprost (> 0.1 mumol/l) causes aggregation of biphasic processes at higher concentrations. Nocloprost activation of platelets is accompanied by thromboxen A2 formation and an increase in cytoplasmic calcium in platelets containing Indo 1. Nocloprost(0.1 μM/L) enhanced aggregation induced by low concentrations of ADP or adrenaline. [2]
In vivo
Nocloprost (0.01-100 μg/kg, intragastric administration) is dose-dependent in preventing the formation of gastric lesions.
Nocloprost (0.01-100 μg/kg, gavage) did not affect gastric acid secretion or intestinal secretion in rats, but prevented the increase of gastroduodenal alkaline secretion. [1]
AliasZK94726, ZK84726, ZK 94726, ZK 84726, SH475, SH 475
Chemical Properties
Molecular Weight400.98
FormulaC22H37ClO4
Cas No.79360-43-3
SmilesC(=C/[C@H](C(CCCC)(C)C)O)\[C@@H]1[C@@H](C/C=C\CCCC(O)=O)[C@H](Cl)C[C@H]1O
Relative Density.1.1g/cm3
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Nocloprost | purchase Nocloprost | Nocloprost cost | order Nocloprost | Nocloprost chemical structure | Nocloprost in vivo | Nocloprost in vitro | Nocloprost formula | Nocloprost molecular weight